{"ok":true,"trend":{"id":614618,"platform":"news","region":"global","key":"rethinking reproducibility in advanced 3d cell models","title":"Rethinking reproducibility in advanced 3D cell models","url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQMkJ1Ukx2c05PSXZPcGhGcklYUjBseHQ4c1BnMExITFRfWmVMcEFfM0JlN0R6RmZ1a1l1MjBxS29JWW5Sb3JPOW80T1NDRV9WYWtpcENxeUN1WVM3S3p5Y1RpVjc0NUQ5TGpuWTVwclU0cWJ4Q09Ub3F6d1FPaUlBMVcwcFVIZjdRT2FMQXppQnRabHUwWVFiYw?oc=5","first_seen":"2026-10-01T13:42:19.267725Z","last_seen":"2026-10-02T07:34:11.730270Z","last_rank":27,"peak_rank":2,"last_volume":null,"peak_volume":0,"seen_count":14,"score":41.08,"category_hint":"biology","section":"science","category":"biology","summary":"Drug Discovery News is examining how reproducibility challenges affect advanced 3D cell models used in biomedical research. The discussion centers on whether organoids and spheroid cultures can produce consistent, comparable results across laboratories, a persistent hurdle as these models become central to drug discovery and disease study.","why":"unclear","tone":"neutral","entities":["Drug Discovery News","3D cell models"],"summarized_at":"2026-10-02T01:45:39.714642Z","meta":{"via":"scan","lang":"en","term":"biology","source":"Drug Discovery News","published":"Thu, 01 Oct 2026 17:31:37 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Rethinking reproducibility in advanced 3D cell models","section_name":"Science","category_name":"Biology","timeline":[{"captured_at":"2026-10-01T13:42:19.267725Z","rank":2,"volume":null},{"captured_at":"2026-10-01T15:04:18.250885Z","rank":4,"volume":null},{"captured_at":"2026-10-01T16:26:19.316632Z","rank":7,"volume":null},{"captured_at":"2026-10-01T17:48:19.049488Z","rank":9,"volume":null},{"captured_at":"2026-10-01T19:10:41.087819Z","rank":15,"volume":null},{"captured_at":"2026-10-01T20:33:21.362751Z","rank":20,"volume":null},{"captured_at":"2026-10-01T21:55:24.388039Z","rank":25,"volume":null},{"captured_at":"2026-10-01T23:17:23.051275Z","rank":25,"volume":null},{"captured_at":"2026-10-02T00:39:21.063219Z","rank":26,"volume":null},{"captured_at":"2026-10-02T02:01:43.265348Z","rank":16,"volume":null},{"captured_at":"2026-10-02T03:27:11.422171Z","rank":21,"volume":null},{"captured_at":"2026-10-02T04:49:48.761644Z","rank":25,"volume":null},{"captured_at":"2026-10-02T06:11:50.774798Z","rank":25,"volume":null},{"captured_at":"2026-10-02T07:34:11.730270Z","rank":27,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQMkJ1Ukx2c05PSXZPcGhGcklYUjBseHQ4c1BnMExITFRfWmVMcEFfM0JlN0R6RmZ1a1l1MjBxS29JWW5Sb3JPOW80T1NDRV9WYWtpcENxeUN1WVM3S3p5Y1RpVjc0NUQ5TGpuWTVwclU0cWJ4Q09Ub3F6d1FPaUlBMVcwcFVIZjdRT2FMQXppQnRabHUwWVFiYw?oc=5","author":"Drug Discovery News","title":"Rethinking reproducibility in advanced 3D cell models","snippet":null,"posted_at":"2026-10-01T12:33:35Z","likes":null}],"elsewhere":[],"window":"7d"}}